Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$2.94B |
| 2 |
Amazon
AMZN
|
+$1.22B |
| 3 |
NVIDIA
NVDA
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$1.01B |
| 5 |
Procter & Gamble
PG
|
+$784M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$619M |
| 2 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$582M |
| 3 |
Phillips 66
PSX
|
+$575M |
| 4 |
Eli Lilly
LLY
|
+$377M |
| 5 |
HES
Hess
HES
|
+$326M |
Sector Composition
| 1 | Technology | 31.4% |
| 2 | Financials | 12.71% |
| 3 | Consumer Discretionary | 10.47% |
| 4 | Healthcare | 9.99% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Elanco Animal Health
ELAN
$9.33B
| $5.6M | ﹤0.01% |
343,659
-172,898
| -33% | -$2.82M |
|
|
LSXMK
1302
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $5.59M | ﹤0.01% |
188,133
+786
| +0.4% | +$23.4K |
|
1303
Bank of Hawaii
BOH
$2.74B
| $5.58M | ﹤0.01% |
89,361
-24,227
| -21% | -$1.51M |
|
1304
Frontier Communications
FYBR
$9.38B
| $5.56M | ﹤0.01% |
226,970
+26,984
| +13% | +$661K |
|
1305
Bausch Health
BHC
$2.68B
| $5.55M | ﹤0.01% |
523,245
-315,541
| -38% | -$3.35M |
|
1306
Ultragenyx Pharmaceutical
RARE
$3.01B
| $5.55M | ﹤0.01% |
118,773
-47,969
| -29% | -$2.24M |
|
1307
ICU Medical
ICUI
$3.33B
| $5.54M | ﹤0.01% |
51,650
+47,081
| +1,030% | +$5.05M |
|
1308
Establishment Labs
ESTA
$1.1B
| $5.54M | ﹤0.01% |
108,797
+105,466
| +3,166% | +$5.37M |
|
1309
Federal Signal
FSS
$7.77B
| $5.53M | ﹤0.01% |
65,220
-41,626
| -39% | -$3.53M |
|
1310
Rhythm Pharmaceuticals
RYTM
$6.5B
| $5.53M | ﹤0.01% |
127,536
-123,879
| -49% | -$5.37M |
|
1311
JELD-WEN Holding
JELD
$566M
| $5.43M | ﹤0.01% |
255,723
+47,598
| +23% | +$1.01M |
|
1312
Neogen
NEOG
$1.25B
| $5.42M | ﹤0.01% |
343,675
-142,120
| -29% | -$2.24M |
|
1313
Grocery Outlet
GO
$1.75B
| $5.41M | ﹤0.01% |
188,039
+64,506
| +52% | +$1.86M |
|
1314
Wendy's
WEN
$1.88B
| $5.38M | ﹤0.01% |
285,350
+26,484
| +10% | +$499K |
|
1315
Pliant Therapeutics
PLRX
$101M
| $5.37M | ﹤0.01% |
360,145
+7,248
| +2% | +$108K |
|
1316
Genpact
G
$7.55B
| $5.36M | ﹤0.01% |
162,580
+29,652
| +22% | +$977K |
|
|
SLRN
1317
DELISTED
ACELYRIN
SLRN
| $5.35M | ﹤0.01% |
793,170
+743,686
| +1,503% | +$5.02M |
|
1318
Petrobras
PBR
$81.6B
| $5.34M | ﹤0.01% |
351,382
+22,009
| +7% | +$335K |
|
1319
TORM
TRMD
$2.16B
| $5.33M | ﹤0.01% |
152,488
+6,398
| +4% | +$224K |
|
1320
EPR Properties
EPR
$4.31B
| $5.33M | ﹤0.01% |
125,515
+50,493
| +67% | +$2.14M |
|
1321
Lincoln National
LNC
$7.99B
| $5.33M | ﹤0.01% |
166,747
-28,838
| -15% | -$921K |
|
1322
Vanguard Intermediate-Term Bond ETF
BIV
$24.3B
| $5.33M | ﹤0.01% |
70,619
-10,976
| -13% | -$828K |
|
1323
Ambarella
AMBA
$3.55B
| $5.32M | ﹤0.01% |
104,869
+28,289
| +37% | +$1.44M |
|
|
GTM
1324
ZoomInfo Technologies
GTM
$3.74B
| $5.32M | ﹤0.01% |
331,969
-421,291
| -56% | -$6.75M |
|
1325
Invesco Taxable Municipal Bond ETF
BAB
$925M
| $5.31M | ﹤0.01% |
200,000
| – | – |
|